Task: Answer the multiple-choice question.
Query: Which drug exhibits a -0.971% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCCc1c2c(cc3c(=O)cc(C(=O)OCC)oc13)CCCC2
b) c1ccc(N2CCN(c3ncnc4c3oc3ccccc34)CC2)cc1
Answer: a. CCCc1c2c(cc3c(=O)cc(C(=O)OCC)oc13)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1c2c(cc3c(=O)cc(C(=O)OCC)oc13)CCCC2
CCCc1c2c(cc3c(=O)cc(C(=O)OCC)oc13)CCCC2
ethyl 4-oxo-10-propyl-6,7,8,9-tetrahydrobenzo[g]chromene-2-carboxylate